-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Relay Therapeutics, Raises Price Target to $19

Benzinga·04/28/2026 14:03:50
Listen to the news
Citizens analyst Silvan Turkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and raises the price target from $17 to $19.